Global lipid based formulations market is anticipated to grow with an impressive CAGR in the forecast period, 2023-2027, on account of growing pharmaceutical industry. Rapidly surging demands for the advanced medicine and growing demand for oral administrated medicine is driving the growth of the global lipid formulations market in the upcoming five years.
Lipid based formulations are bio-chemical compounds that are artificially synthesized to facilitate the drug administration, while ensuring safety of the drug along with bio-solubility of it for the digestion and faster action of the main drug component inside the formulation. Lipid based formulations aid the primary mechanism of action for the drug that leads to bioavailability.
In simpler terms, highly water soluble drugs if gets dissolved in the starting of gut, may not reach the target site, or target organ and thus its efficiency decreases. To alter this effect, a lipid based formulation is utilized. Lipids form a hydrophobic bonds around the drug and avoid dissolution partially or completely until it reaches the target site. With digestion of the lipid bonds by the process of triglyceride digestion, the drug gets delivered in the later parts of gastrointestinal tract.
Pharmaceutical Advancements Drive Market Growth
Consistent research and development of the drugs such that they have higher bio-availability, higher effect on the target site, to improve facilitation of the drug to create its effect at the target site, is driving the growth of the global lipid based formulations market in the upcoming five years. A major concern among the drug delivery system is that, for the oral administration of the drug, it has tendency to get dissolved or digested before reaching the target site.
In such cases, the drug if get dissolved would leave the gastrointestinal tract without being absorbed in the blood. To avoid this untimely dissolution, lipid based formulations are utilized to enhance the drug durability and absorption thus substantially increasing its affinity as a treatment for a particular diseases.
Growing Investments In Healthcare Industry Supports Market
Governments from major economies are actively investing in their respective healthcare sectors to enhance the services and products such that best possible patient care can be provided. Increasing instances of chronic, infectious, and communicable diseases, is further anticipated to drive the growth of the global lipid based formulations market in the upcoming five years.
Consistent research and technological advancement for the pharmaceutical product development and advancement of the drug delivery systems, is also anticipated to substantiate the growth of the global lipid based formulations market in the future five years.
Click here to download the sample
Market Segmentation
The global lipid based formulations market segmentation is based on source of lipids, application, distribution channel, regional distribution, and competitive landscape. Based on source of lipids, the market is differentiated between natural and chemically synthesized sources. Application based segments of the market is distinguished among fungal diseases, oncology, gene therapy, antiviral vaccines, and others.
Based on distribution channel, the market is fragmented into retail pharmacies, hospital pharmacies, and online pharmacies.
Company Profile
Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., are enlisted in a partial list of major market players of the global lipid based formulations market.
| Attribute | Details |
| Base Year | 2021 |
| Historical Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | - Source of Lipid
- Application
- Distribution Channel
|
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia. |
| Key companies profiled | Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
